Drug coated balloon versus drug eluting stent in primary percutaneous coronary intervention: a feasibility study. - DCB vs. DES in pPCI: a feasibility study.

Clinical hospital center Rijeka0 sites75 target enrollmentFebruary 13, 2017

Overview

No summary available.

Registry

who.int

Start Date

February 13, 2017

End Date

January 31, 2015

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

Clinical hospital center Rijeka

•Inclusion criteria were: 1\) STEMI presenting less than 12 hours from symptoms onset; 2\) de novo lesion: coronary artery occlusion or critical stenosis; 3\) coronary artery diameter from 2\.5 to 4\.0 mm.

•Exclusion criteria were: 1\) stroke within the last six months; 2\) likelihood of survival less than one year; 3\) pregnancy or breastfeeding; 4\) The Modification of Diet in Renal Disease (MDRD) derived eGFR \<30 ml/min/1,73 m2; 5\) in stent restenosis; 6\) extensive coronary disease needing additional revascularization; 7\) PCI or coronary artery bypass graft (CABG) surgery within the last six months; 8\) severe coronary artery tortuosity; 9\) hypersensitivity, allergies and other contraindications to acetylsalicylic acid, clopidogrel, heparin, paclitaxel or eptifibatide; 10\) allergies to iodine\-containing contrast medium; 11\) leucocytes count \<3,5 x 10^9/L and platelets count \<75 x 10^9/L or \>650 x 10^9/L.